Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea-Reference-Cited by-同舟云学术

Gut microbiota profiles and fecal beta‐glucuronidase activity in kidney transplant recipients with and without post‐transplant diarrhea

Published:2021-03-09 Issue:5 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Zhang Lisa T.¹,Westblade Lars F.²³,Iqbal Fatima⁴⁵,Taylor Michael R.⁴⁵,Chung Alice¹,Satlin Michael J.³,Magruder Matthew¹,Edusei Emmanuel¹,Albakry Shady¹,Botticelli Brittany¹,Robertson Amy⁶,Alston Tricia⁶,Dadhania Darshana M.¹⁷^ORCID,Lubetzky Michelle¹⁷^ORCID,Hirota Simon A.⁸,Greenway Steven C.⁴⁵,Lee John R.¹⁷^ORCID

Affiliation:

1. Department of Medicine Division of Nephrology and Hypertension Weill Cornell Medicine New York NY USA

2. Department of Pathology and Laboratory Medicine Weill Cornell Medicine New York NY USA

3. Department of Medicine Division of Infectious Diseases Weill Cornell Medicine New York NY USA

4. Departments of Pediatrics and Biochemistry and Molecular Biology Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary Calgary AB Canada

5. Department of Cardiac Sciences Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary Calgary AB Canada

6. New York Presbyterian Hospital ‐ Weill Cornell Medical Center New York NY USA

7. Department of Transplantation Medicine NewYork‐Presbyterian Hospital – Weill Cornell Medical Center New York NY USA

8. Department of Physiology and Pharmacology Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary Calgary AB Canada

Funder

W. Garfield Weston Foundation

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14260

Reference29 articles.

1. Diagnosis and management of diarrhea in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

2. MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION: 3-YEAR RESULTS FROM THE PLACEBO-CONTROLLED TRIAL1